Kras - Kirsten rat sarcoma viral oncogene homolog Gene
Also Known as ras; p21B; K-Ras; K-ras; Kras2; Ki-ras; Kras-2; K-Ras 2; c-K-ras; c-Ki-ras
Species: Mus musculus
About Kras
This gene has 7 transcripts (splice variants), 201 orthologues, 35 paralogues and is associated with 90 phenotypes. Ubiquitous expression in CNS E18 (RPKM 17.), whole brain E14.5 (RPKM 16.2) and 26 other tissues.
Summary
Enables GTPase activity. Involved in endocrine signaling. Acts upstream of or within several processes, including forebrain astrocyte development; modulation of chemical synaptic transmission; and positive regulation of Rac protein signal transduction. Located in membrane. Is expressed in several structures, including brain; early embryo; eye; genitourinary system; and gut. Used to study several diseases, including Noonan syndrome 3; carcinoma (multiple); juvenile myelomonocytic leukemia; lung cancer; and Prostate Cancer. Human ortholog(s) of this gene implicated in several diseases, including Noonan syndrome (multiple); arteriovenous malformations of the brain; cardiofaciocutaneous syndrome (multiple); gastrointestinal system Cancer (multiple); and hematologic Cancer (multiple). Orthologous to human KRAS (KRAS proto-oncogene, GTPase). [provided by Alliance of Genome Resources, Apr 2022]
Kras Products (8)
| mRNA | Protein | Name |
|---|---|---|
| NM_001403242.1 | NP_001390171.1 | GTPase KRas isoform 1 |
| NM_001403245.1 | NP_001390174.1 | GTPase KRas isoform 3 |
| NM_001403241.1 | NP_001390170.1 | GTPase KRas isoform 1 |
| NM_001403246.1 | NP_001390175.1 | GTPase KRas isoform 4 |
| NM_021284.7 | NP_067259.4 | GTPase KRas isoform 1 |
| NM_001403243.1 | NP_001390172.1 | GTPase KRas isoform 2 |
| NM_001403240.1 | NP_001390169.1 | GTPase KRas isoform 1 |
| NM_001403244.1 | NP_001390173.1 | GTPase KRas isoform 3 |
Gene Ontology
- Molecular Function
- Biological Process
- Cellular Component
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables GTPase activity |
IGI
IGI: Inferred from genetic interaction
|
15665300 | MGI |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
15102471 | MGI |
| enables protein-membrane adaptor activity |
IDA
IDA: Inferred from direct assay
|
12354753 | MGI |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in membrane |
IDA
IDA: Inferred from direct assay
|
10085069 | MGI |
| located in membrane |
IGI
IGI: Inferred from genetic interaction
|
14966563 | MGI |
Kras Protein Structure
H_N_K_Ras_like: cd04138 (2 - 163)
- 0
- 100
- 188 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
GTPase KRas |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-114277 | Sotorasib | Inhibitor | 99.70% | Yes |
| HY-130149 | Adagrasib | Inhibitor | 99.96% | Unkown |
| HY-114277A | Sotorasib racemate | 98.99% | Unkown | |
| HY-B0984 | Fendiline hydrochloride | 99.78% | Unkown | |
| HY-B0984A | Fendiline | 99.41% | Unkown | |
| HY-114277R | Sotorasib (Standard) | Inhibitor | 99.25% | Unkown |
| HY-B0984R | Fendiline hydrochloride (Standard) | 99.76% | Unkown |
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-132844 | Tunlametinib | Inhibitor | 99.53% | Phase 4 |
| HY-176785S | MCB-294 | 98.04% | Phase 4 | |
| HY-148439 | Daraxonrasib | Inhibitor | 99.96% | Phase 3 |
| HY-16909 | Leptomycin B | Inhibitor | 99.79% | Phase 3 |
| HY-145928 | Divarasib | Inhibitor | 99.31% | Phase 3 |
| HY-148273 | Setidegrasib | Inhibitor | 99.65% | Phase 3 |
| HY-159127 | HRS-4642 | 99.74% | Phase 3 | |
| HY-132980 | Olomorasib | Inhibitor | 99.88% | Phase 3 |
| HY-143589 | Glecirasib | Inhibitor | 99.20% | Phase 3 |
| HY-139612 | Opnurasib | Inhibitor | 98.20% | Phase 3 |
| HY-162431 | Calderasib | Inhibitor | 99.82% | Phase 3 |
| HY-139612A | (S)-Opnurasib | Inhibitor | 98.11% | Phase 3 |
| HY-139612B | (Rac)-Opnurasib | Inhibitor | / | Phase 3 |
| HY-156819 | Zoldonrasib | 99.73% | Phase 2 | |
| HY-153346 | Elironrasib | 99.91% | Phase 2 | |
| HY-152848 | Fulzerasib | Inhibitor | 99.60% | Phase 2 |
| HY-160023 | Elisrasib | 99.68% | Phase 2 | |
| HY-114491A | Rineterkib hydrochloride | Inhibitor | 99.87% | Phase 2 |
| HY-180200 | RNK08954 | Inhibitor | / | Phase 2 |
| HY-158115 | NST-628 | Inhibitor | 99.35% | Phase 1 |
| HY-173632 | AMG410 | Inhibitor | 99.75% | Phase 1 |
| HY-173629 | RMC-5127 | 99.96% | Phase 1 | |
| HY-158107 | BBO-8520 | Inhibitor | 99.90% | Phase 1 |
| HY-159852 | BBO-10203 | 99.12% | Phase 1 | |
| HY-156002 | LUNA18 | Inhibitor | 99.76% | Phase 1 |
| HY-147245 | Basroparib | Inhibitor | 98.91% | Phase 1 |
| HY-15610 | GDC-0623 | 98.74% | Phase 1 | |
| HY-16111 | BMS-214662 | Inhibitor | 99.86% | Phase 1 |
| HY-173637 | AZD0022 | Inhibitor | 98.36% | Phase 1 |
| HY-16373 | CP-609754 | Inhibitor | 99.49% | Phase 1 |
| HY-176954 | RSC-1255 | 99.91% | Phase 1 | |
| HY-134813A | MRTX1133 formic | Inhibitor | 98.23% | Phase 1 |
| HY-158107A | (4R)-BBO-8520 | Inhibitor | / | Phase 1 |
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P991571 | GC1118 | Inhibitor | 99.22% | Phase 2 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-134813 | MRTX1133 | Inhibitor | 99.97% | Unkown |
| HY-156498 | RMC-7977 | Inhibitor | 99.48% | Unkown |
| HY-153724 | BI-2865 | 99.16% | Unkown | |
| HY-147214 | GNE-7883 | Inhibitor | 99.54% | Unkown |
| HY-125817 | BI-3406 | Inhibitor | 99.95% | Unkown |
| HY-157228 | ACBI3 | Degrader | 99.47% | Unkown |
| HY-160699 | DCC-3116 | Inhibitor | 99.84% | Unkown |
| HY-112929 | DT-061 | Activator | 99.95% | Unkown |
| HY-126247 | BI-2852 | Inhibitor | 99.46% | Unkown |
| HY-171135 | Cetuximab MMAE | Inhibitor | 99.64% | Unkown |
| HY-135985 | DCLK1-IN-1 | 99.35% | Unkown | |
| HY-15872A | FTI-277 hydrochloride | 98.06% | Unkown | |
| HY-153723 | BI-2493 | Inhibitor | 99.79% | Unkown |
| HY-W599085 | tert-Butyl (6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-((triisopropylsilyl)ethynyl)naphthalen-2-yl)carbamate | 99.79% | Unkown | |
| HY-114398 | BAY-293 | Inhibitor | 98.97% | Unkown |
| HY-137516 | LC-2 | 98.48% | Unkown | |
| HY-138188 | KRA-533 | Agonist | 98.73% | Unkown |
| HY-159788 | PROTAC K-Ras Degrader-4 | Degrader | 99.01% | Unkown |
| HY-123941 | FKBP12 PROTAC dTAG-7 | 99.47% | Unkown | |
| HY-19713 | LJI308 | Inhibitor | 99.07% | Unkown |
| HY-U00418 | ARS-1620 | Inhibitor | 99.59% | Unkown |
| HY-128350 | FGTI-2734 | Inhibitor | 99.85% | Unkown |
| HY-161176 | PROTAC KRAS G12D degrader 1 | 98.32% | Unkown | |
| HY-W095670 | 2,4,7-Trichloro-8-fluoropyrido[4,3-d]pyrimidine | 99.95% | Unkown | |
| HY-128574 | D927 | Activator | 99.46% | Unkown |
| HY-136265 | BC-LI-0186 | Inhibitor | 99.37% | Unkown |
| HY-122862 | RAS inhibitor Abd-7 | Inhibitor | 99.57% | Unkown |
| HY-148098 | AM-2383 | Inhibitor | 99.31% | Unkown |
| HY-18303 | AMG-47a | Inhibitor | 99.19% | Unkown |
| HY-176786 | MCB-36 | 98.43% | Unkown | |
| HY-162809 | XMU-MP-9 | 99.12% | Unkown | |
| HY-129523 | PROTAC K-Ras Degrader-1 | Inhibitor | 99.90% | Unkown |
| HY-148409 | MMRi62 | 99.59% | Unkown | |
| HY-159190 | HRX-0233 | 98.92% | Unkown | |
| HY-N0735 | Phellodendrine chloride | 99.68% | Unkown | |
| HY-156671 | RMC-4998 | 99.31% | Unkown | |
| HY-176134 | RP03707 | Degrader | 98.00% | Unkown |
| HY-114436 | MRTX-1257 | Inhibitor | 99.71% | Unkown |
| HY-18707 | K-Ras(G12C) inhibitor 12 | 99.57% | Unkown | |
| HY-15747 | Deltarasin | Inhibitor | 99.12% | Unkown |
| HY-13495 | ML281 | 98.04% | Unkown | |
| HY-106381 | Aurothiomalate sodium | Inhibitor | 98.0% | Unkown |
| HY-W016889 | CFL-137 | Inhibitor | 99.92% | Unkown |
| HY-101354 | R-IMPP | 99.93% | Unkown | |
| HY-122914 | KRAS inhibitor-3 | Inhibitor | 99.87% | Unkown |
| HY-135700 | Mevalonolactone | 98.0% | Unkown | |
| HY-W095672A | (2R,7aS)-2-Fluorotetrahydro-1H-pyrrolizine-7a(5H)-methanol | 99.82% | Unkown | |
| HY-173405 | VVD-699 | Inhibitor | 99.83% | Unkown |
| HY-128522 | ARS-1323-alkyne | Inhibitor | 99.59% | Unkown |
| HY-137497 | KRAS inhibitor-9 | 99.85% | Unkown | |
| HY-139186 | PROTAC KRAS G12C degrader-1 | Degrader | 99.15% | Unkown |
| HY-147025 | (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine | 98.62% | Unkown | |
| HY-49385 | E3 ligase Ligand 64 | ≥98.0% | Unkown | |
| HY-147099 | dTAG-47-NEG | Control | 98.93% | Unkown |
| HY-168054 | PROTAC K-Ras Degrader-3 | Degrader | 99.75% | Unkown |
| HY-176523 | KRAS G12D-IN-29 | Inhibitor | 99.93% | Unkown |
| HY-114491 | Rineterkib | Inhibitor | 98.79% | Unkown |
| HY-15879 | LB42708 | ≥99.0% | Unkown | |
| HY-128350A | FGTI-2734 mesylate | Inhibitor | 99.81% | Unkown |
| HY-154959 | AZD4747 | Inhibitor | 99.07% | Unkown |
| HY-175870 | Eras-4001 | Inhibitor | 98.27% | Unkown |
| HY-138295 | KRAS inhibitor-10 | Inhibitor | 99.92% | Unkown |
| HY-161233A | BTX-6654 formate | 98.85% | Unkown | |
| HY-161906 | SD-066-4 | Inhibitor | 99.96% | Unkown |
| HY-168221 | YD54 | Degrader | 98.74% | Unkown |
| HY-W1126235 | DS02312223 | Activator | 98.24% | Unkown |
| HY-19706 | ARS-853 | 98.39% | Unkown | |
| HY-151523 | KRas G12R inhibitor 1 | Inhibitor | 98.40% | Unkown |
| HY-134654 | MRTX849 analog 24 | Inhibitor | 98.01% | Unkown |
| HY-159652 | KRAS inhibitor-31 | Inhibitor | 99.36% | Unkown |
| HY-181420A | BBO-11818 | 99.77% | Unkown | |
| HY-41832 | 4,6-Dichloro-2-(methylthio)pyrimidine | 99.32% | Unkown | |
| HY-76986 | 5-Iodoindolin-2-one | 99.25% | Unkown | |
| HY-15873A | FTI 276 TFA | Inhibitor | 98.31% | Unkown |
| HY-18674 | K-Ras-IN-1 | Inhibitor | 98.00% | Unkown |
| HY-106381A | Aurothiomalate tetramer sodium | Inhibitor | 98.0% | Unkown |
| HY-114277B | Sotorasib isomer | Control | 98.85% | Unkown |
| HY-139047 | SW157765 | Inhibitor | 98.08% | Unkown |
| HY-146243 | TH-Z835 | 99.58% | Unkown | |
| HY-156529 | pan-KRAS-IN-2 | Inhibitor | 98.01% | Unkown |
| HY-162960 | pan-KRAS-IN-18 | Degrader | 99.93% | Unkown |
| HY-P2265A | SAH-SOS1A TFA | Inhibitor | 96.55% | Unkown |
| HY-P3277 | KRpep-2d | Inhibitor | 96.51% | Unkown |
| HY-16662 | Oncrasin-1 | 98.16% | Unkown | |
| HY-U00416 | ARS-1323 | Inhibitor | 99.67% | Unkown |
| HY-147008 | XP-524 | Inhibitor | 98.02% | Unkown |
| HY-128590 | PHT-7.3 | Inhibitor | 99.29% | Unkown |
| HY-145320 | TMX-4113 | Inhibitor | 99.08% | Unkown |
| HY-114277S | Sotorasib-d7 | Inhibitor | 98.90% | Unkown |
| HY-125847 | Salvianolic acid F | 99.50% | Unkown | |
| HY-126247B | (R)-BI-2852 | Control | 97.32% | Unkown |
| HY-161177 | PROTAC SARS-CoV-2 3CLPro degrader 2 | Degrader | 98.59% | Unkown |
| HY-168215 | YDR1 | Degrader | 98.06% | Unkown |
| HY-177106 | ADT-1004 | Inhibitor | 98.16% | Unkown |
| HY-P10436 | Braftide | Inhibitor | 99.51% | Unkown |
| HY-145928B | Divarasib adipate | Inhibitor | 99.20% | Unkown |
| HY-172237 | Sosimerasib | Inhibitor | 98.63% | Unkown |
| HY-145962A | MRTX-EX185 formic | Inhibitor | 97.15% | Unkown |
| HY-151517 | SOS1-IN-14 | Inhibitor | 99.60% | Unkown |
| HY-16967 | MM41 | 98.89% | Unkown | |
| HY-104067 | Naphthol AS-MX phosphate | Inhibitor | 99.50% | Unkown |
| HY-136726 | CGP-82996 | Inhibitor | 98.12% | Unkown |
| HY-153663 | TH-Z827 | Inhibitor | 95.12% | Unkown |
| HY-156500 | ICMT-IN-1 | Inhibitor | 98.43% | Unkown |
| HY-161235 | BTX-7312 | 98.35% | Unkown | |
| HY-164315 | KRAS G12C inhibitor 67 | Inhibitor | 98.80% | Unkown |
| HY-176792 | ACBI-4 | Degrader | 98.01% | Unkown |
| HY-130991 | K-Ras ligand-Linker Conjugate 6 | / | Unkown | |
| HY-141477 | RM-018 | Inhibitor | 95.95% | Unkown |
| HY-163939 | RGT-018 | Inhibitor | 99.77% | Unkown |
| HY-168847 | INCB159020 | Inhibitor | / | Unkown |
| HY-170428 | IPS-06061 | Degrader | / | Unkown |
| HY-132966 | ASP2453 | Inhibitor | 98.28% | Unkown |
| HY-144661 | KRAS G12D inhibitor 14 | 98.88% | Unkown | |
| HY-115880A | KRAS G12D inhibitor 3 TFA | Inhibitor | 98.18% | Unkown |
| HY-134977 | Atrovastatin-PEG3-FITC | Inhibitor | 99.23% | Unkown |
| HY-145737A | PROTAC SOS1 degrader-1 TFA | 98.38% | Unkown | |
| HY-155356 | YN14 | 99.08% | Unkown | |
| HY-159474 | KRAS inhibitor-24 | Inhibitor | 95.03% | Unkown |
| HY-159474A | (1R)-KRAS inhibitor-24 | Inhibitor | 98.29% | Unkown |
| HY-159591 | YK-8S | Inhibitor | / | Unkown |
| HY-168669 | PROTAC K-Ras Degrader-5 | 97.84% | Unkown | |
| HY-177511 | KRAS G12D-IN-30 | Inhibitor | 99.38% | Unkown |
| HY-P5192 | KRAS G12D(8-16) | 97.73% | Unkown | |
| HY-W041315 | CFL-120 | Inhibitor | 98.0% | Unkown |
| HY-W998345 | SMART1 | Inhibitor | 99.87% | Unkown |
| HY-157029S | KRASG12D-IN-1 | Inhibitor | 98.00% | Unkown |
| HY-115489A | GGTI-286 TFA | Inhibitor | / | Unkown |
| HY-142160 | GNE-9815 | Inhibitor | 98.94% | Unkown |
| HY-151881 | SOS1-IN-15 | Inhibitor | 98.04% | Unkown |
| HY-107720 | ARL 17477 | Inhibitor | 98.88% | Unkown |
| HY-122641 | Deltasonamide 1 | Inhibitor | 99.15% | Unkown |
| HY-134811 | KRAS G12D inhibitor 1 | Inhibitor | 98.51% | Unkown |
| HY-143599 | KRAS G12D inhibitor 8 | Inhibitor | / | Unkown |
| HY-145615 | Pomalidomide-C12-NH2 hydrochloride | 96.51% | Unkown | |
| HY-153821 | PROTAC KRAS G12C degrader-2 | Degrader | 98.45% | Unkown |
| HY-154313 | Spiclomazine | Inhibitor | 99.56% | Unkown |
| HY-156671A | RMC-4998 formic | 99.02% | Unkown | |
| HY-161066 | KRAS G13D-IN-1 | Inhibitor | / | Unkown |
| HY-162445 | KRASG12D-IN-3 | Inhibitor | 98.38% | Unkown |
| HY-163299 | pan-KRAS-IN-5 | 96.70% | Unkown | |
| HY-163594 | KRAS-IN-59 | Inhibitor | 99.66% | Unkown |
| HY-163595 | KRAS G12D-IN-31 | Inhibitor | 98.53% | Unkown |
| HY-164365 | PROTAC K-Ras Degrader-2 | Degrader | / | Unkown |
| HY-168012 | Pan-RAS-IN-6 | Inhibitor | / | Unkown |
| HY-172626A | (R)-KRAS G12D inhibitor 28 hydrochloride dihydrate | Inhibitor | 99.58% | Unkown |
| HY-173637A | (S)-AZD0022 | Inhibitor | 95.16% | Unkown |
| HY-178194 | SHY-855 | Inhibitor | 98.54% | Unkown |
| HY-N0427 | Phellodendrine | 99.60% | Unkown | |
| HY-16111A | BMS-214662 hydrochloride | Inhibitor | 98.54% | Unkown |
| HY-RS07425 | KRAS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-115489 | GGTI-286 | Inhibitor | / | Unkown |
| HY-157031S | KRASG12D-IN-2 | Inhibitor | 98.11% | Unkown |
| HY-U00417 | ARS-1630 | Inhibitor | 98.01% | Unkown |
| HY-139894 | KRAS G12D inhibitor 5 | Inhibitor | / | Unkown |
| HY-145962 | MRTX-EX185 | Inhibitor | / | Unkown |
| HY-158008 | (R)-G12Di-7 | Inhibitor | 98.42% | Unkown |
| HY-161233 | BTX-6654 | / | Unkown | |
| HY-18606 | K-Ras G12C-IN-3 | Inhibitor | 99.94% | Unkown |
| HY-186087 | RM-046 | / | Unkown | |
| HY-125872 | KRAS G12C inhibitor 14 | Inhibitor | 99.00% | Unkown |
| HY-125873 | KRAS G12C inhibitor 15 | Inhibitor | 98.47% | Unkown |
| HY-128771 | K-Ras G12C-IN-4 | Inhibitor | 99.19% | Unkown |
| HY-130707 | K-Ras ligand-Linker Conjugate 3 | / | Unkown | |
| HY-130823 | K-Ras ligand-Linker Conjugate 5 | 99.79% | Unkown | |
| HY-142460 | KRAS G12C inhibitor 28 | Inhibitor | 99.94% | Unkown |
| HY-153262 | (7R)-Elisrasib | Inhibitor | 99.52% | Unkown |
| HY-112491 | KRas G12C inhibitor 1 | Inhibitor | / | Unkown |
| HY-112929B | (1S,2S,3R)-DT-061 | 99.77% | Unkown | |
| HY-114398A | (S)-BAY-293 | 97.8% | Unkown | |
| HY-117935 | GGTI-286 hydrochloride | Inhibitor | / | Unkown |
| HY-123929 | PAWI-2 | 99.29% | Unkown | |
| HY-124761 | Poloppin | Inhibitor | 99.40% | Unkown |
| HY-130819 | Tos-PEG4-THP | 95.0% | Unkown | |
| HY-130820 | THP-PEG4-Pyrrolidine(N-Boc)-CH2OH | 95.0% | Unkown | |
| HY-130821 | THP-PEG4-Pyrrolidine(N-Me)-CH2OH | 95.0% | Unkown | |
| HY-139402 | MRTX849 acid | Inhibitor | 99.84% | Unkown |
| HY-143603 | KRAS G12D inhibitor 10 | Inhibitor | 88.89% | Unkown |
| HY-144657A | (4S)-PROTAC SOS1 degrader-1 diTFA | 98.09% | Unkown | |
| HY-148278 | BI-0474 | Inhibitor | 99.83% | Unkown |
| HY-153413 | Kras4B G12D-IN-1 | Inhibitor | 98.01% | Unkown |
| HY-153662 | TH-Z816 | Inhibitor | 98.92% | Unkown |
| HY-154959A | (9R,12aR)-AZD4747 | Control | 98.90% | Unkown |
| HY-161767 | JWJ-01-306 | Inhibitor | / | Unkown |
| HY-162100 | MR-2088 | Inhibitor | 99.50% | Unkown |
| HY-164350 | KRAS inhibitor-27 | Inhibitor | 98.27% | Unkown |
| HY-164493 | KRASG12C IN-13 | Inhibitor | 99.01% | Unkown |
| HY-164749 | K-Ras-IN-4 | Inhibitor | / | Unkown |
| HY-171255 | QTX3034 | Inhibitor | 98.39% | Unkown |
| HY-176489 | PROTAC pan-KRAS degrader-1 | Degrader | / | Unkown |
| HY-178211 | SHY-867 | Inhibitor | 99.66% | Unkown |
| HY-181555 | IACS-56676 | Inhibitor | / | Unkown |
| HY-183068 | AP4-43 | Inhibitor | 99.76% | Unkown |
| HY-18604 | K-Ras G12C-IN-1 | Inhibitor | 98.19% | Unkown |
| HY-P11294 | KLVVVGADGVGKSALTI | 98.26% | Unkown | |
| HY-P11355A | KRAS WT Peptide TFA | 98.61% | Unkown | |
| HY-P11356A | KRAS G12V Peptide TFA | 97.01% | Unkown | |
| HY-P11357A | KRAS G12C Peptide TFA | Activator | 95.15% | Unkown |
| HY-P3277A | KRpep-2d TFA | Inhibitor | 98.11% | Unkown |
| HY-RS07426 | Kras Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-12446 | K-Ras(G12C) inhibitor 9 | Inhibitor | 98.5% | Unkown |
| HY-15747A | Deltarasin hydrochloride | Inhibitor | 98.07% | Unkown |
| HY-18605 | K-Ras G12C-IN-2 | Inhibitor | 99.21% | Unkown |
| HY-48187 | KRAS inhibitor-39 | 98.36% | Unkown | |
| HY-W595110 | 3-((4-(Piperidin-4-yl)phenyl)amino)piperidine-2,6-dione (hydrochloride) | 99.72% | Unkown | |
| HY-135864 | KRAS inhibitor-6 | Inhibitor | / | Unkown |
| HY-135865 | KRAS inhibitor-7 | Inhibitor | / | Unkown |
| HY-135866 | KRAS inhibitor-8 | Inhibitor | / | Unkown |
| HY-115880 | KRAS G12D inhibitor 3 | Inhibitor | / | Unkown |
| HY-129775 | K-Ras ligand-Linker Conjugate 1 | / | Unkown | |
| HY-129776 | K-Ras ligand-Linker Conjugate 2 | / | Unkown | |
| HY-132920 | KRAS mutant protein inhibitor 1 | Inhibitor | / | Unkown |
| HY-142458 | KRAS G12C inhibitor 27 | Inhibitor | / | Unkown |
| HY-142487 | KRAS G12C inhibitor 32 | Inhibitor | / | Unkown |
| HY-108887 | Anticancer agent 124 | Inhibitor | / | Unkown |
| HY-114168 | KRAS G12C inhibitor 5 | Inhibitor | / | Unkown |
| HY-115516 | BI-1388 | Inhibitor | / | Unkown |
| HY-125874 | KRAS G12C inhibitor 16 | Inhibitor | / | Unkown |
| HY-125875 | KRAS G12C inhibitor 17 | Inhibitor | / | Unkown |
| HY-126292 | KRAS G12C inhibitor 13 | Inhibitor | / | Unkown |
| HY-130260 | KRAS inhibitor-4 | Inhibitor | / | Unkown |
| HY-130822 | K-Ras ligand-Linker Conjugate 4 | 98.76% | Unkown | |
| HY-132979 | KRAS G12C inhibitor 18 | Inhibitor | / | Unkown |
| HY-146544 | KRAS inhibitor-14 | Inhibitor | / | Unkown |
| HY-146546 | KRAS inhibitor-16 | Inhibitor | / | Unkown |
| HY-150927 | G12Si-2 | Inhibitor | / | Unkown |
| HY-151287 | KRAS inhibitor-20 | Inhibitor | / | Unkown |
| HY-162249 | ASP6918 | Inhibitor | / | Unkown |
| HY-183553 | AUBE00 | Inhibitor | / | Unkown |
| HY-108436 | Deltazinone 1 | Inhibitor | 98.79% | Unkown |
| HY-112492 | KRas G12C inhibitor 2 | Inhibitor | / | Unkown |
| HY-112493 | KRas G12C inhibitor 3 | Inhibitor | / | Unkown |
| HY-112494 | KRas G12C inhibitor 4 | Inhibitor | / | Unkown |
| HY-114436S | MRTX-1257-d6 | / | Unkown | |
| HY-115907 | K20 | Inhibitor | / | Unkown |
| HY-115907A | (rac)-K20 | / | Unkown | |
| HY-116428 | L-744832 | / | Unkown | |
| HY-117807 | A-176120 | Inhibitor | / | Unkown |
| HY-120763 | LB42908 | Inhibitor | / | Unkown |
| HY-122152 | Spiclomazine hydrochloride | Inhibitor | / | Unkown |
| HY-122641D | Deltasonamide 1 TFA | Inhibitor | 99.70% | Unkown |
| HY-125335 | Oligomycin D | / | Unkown | |
| HY-126180 | BAY-866 | Inhibitor | / | Unkown |
| HY-128414 | KRAS G12C-IN-72 | Inhibitor | / | Unkown |
| HY-128762 | ML256 | Inhibitor | / | Unkown |
| HY-130991A | K-Ras ligand-Linker Conjugate 6 formate | 98.93% | Unkown | |
| HY-134505 | Avicin G | Inhibitor | / | Unkown |
| HY-13497 | STK33-IN-1 | Inhibitor | / | Unkown |
| HY-137516A | LC-2 epimer | Degrader | / | Unkown |
| HY-137971 | (±)-Spiro-oxanthromicin A | Inhibitor | / | Unkown |
| HY-139403 | MRTX849 ethoxypropanoic acid | Antagonist | / | Unkown |
| HY-139910 | KRAS G12D inhibitor 6 | Inhibitor | / | Unkown |
| HY-139911 | KRAS G12D inhibitor 7 | Inhibitor | / | Unkown |
| HY-142457 | KRAS G12C inhibitor 26 | Inhibitor | / | Unkown |
| HY-142478 | KRAS G12C inhibitor 29 | Inhibitor | / | Unkown |
| HY-142481 | KRAS G12C inhibitor 30 | Inhibitor | / | Unkown |
| HY-142485 | KRAS G12C inhibitor 31 | Inhibitor | / | Unkown |
| HY-142490 | KRAS G12C inhibitor 33 | Inhibitor | / | Unkown |
| HY-142511 | KRAS G12C inhibitor 34 | Inhibitor | / | Unkown |
| HY-142945 | KRAS G12C inhibitor 43 | Inhibitor | / | Unkown |
| HY-142946 | KRAS G12C inhibitor 44 | Inhibitor | / | Unkown |
| HY-142947 | KRAS G12C inhibitor 45 | Inhibitor | / | Unkown |
| HY-142948 | KRAS G12C inhibitor 46 | Inhibitor | / | Unkown |
| HY-143359 | COTI-219 | Inhibitor | / | Unkown |
| HY-143588 | KRAS G12C inhibitor 35 | Inhibitor | / | Unkown |
| HY-143590 | KRAS G12C inhibitor 37 | Inhibitor | / | Unkown |
| HY-143591 | KRAS G12C inhibitor 38 | Inhibitor | / | Unkown |
| HY-143592 | KRAS G12C inhibitor 39 | Inhibitor | / | Unkown |
| HY-143594 | KRAS G12C inhibitor 40 | Inhibitor | / | Unkown |
| HY-143596 | KRAS G12C inhibitor 41 | Inhibitor | / | Unkown |
| HY-143598 | KRAS G12C inhibitor 42 | Inhibitor | / | Unkown |
| HY-143602 | KRAS G12D inhibitor 9 | Inhibitor | / | Unkown |
| HY-143604 | KRAS G12D inhibitor 11 | Inhibitor | / | Unkown |
| HY-143606 | KRAS G12D inhibitor 12 | Inhibitor | / | Unkown |
| HY-143607 | KRAS G12D inhibitor 13 | Inhibitor | / | Unkown |
| HY-144207 | SOS1-IN-9 | Inhibitor | / | Unkown |
| HY-144210 | SOS1-IN-6 | Inhibitor | / | Unkown |
| HY-144211 | SOS1-IN-7 | Inhibitor | / | Unkown |
| HY-144213 | SOS1-IN-10 | Inhibitor | / | Unkown |
| HY-144323 | YF135 | / | Unkown | |
| HY-144657 | (4S)-PROTAC SOS1 degrader-1 | / | Unkown | |
| HY-145017 | KRAS G12C inhibitor 20 | Inhibitor | / | Unkown |
| HY-145018 | KRAS G12C inhibitor 21 | Inhibitor | / | Unkown |
| HY-145019 | KRAS G12C inhibitor 22 | Inhibitor | / | Unkown |
| HY-145020 | KRAS G12C inhibitor 23 | Inhibitor | / | Unkown |
| HY-145022 | KRAS G12C inhibitor 25 | Inhibitor | / | Unkown |
| HY-145047 | SOS1-IN-4 | Inhibitor | / | Unkown |
| HY-145048 | SOS1-IN-5 | Inhibitor | / | Unkown |
| HY-145436 | KRAS inhibitor-11 | Inhibitor | / | Unkown |
| HY-145737 | PROTAC SOS1 degrader-1 | / | Unkown | |
| HY-146061 | KRAS G12C inhibitor 48 | Inhibitor | / | Unkown |
| HY-146475 | KRAS inhibitor-17 | Inhibitor | / | Unkown |
| HY-146476 | KRAS inhibitor-18 | Inhibitor | / | Unkown |
| HY-146533 | KRAS inhibitor-12 | Inhibitor | / | Unkown |
| HY-146537 | KRAS G12C inhibitor 47 | Inhibitor | / | Unkown |
| HY-146543 | KRAS inhibitor-13 | Inhibitor | / | Unkown |
| HY-146545 | KRAS inhibitor-15 | Inhibitor | / | Unkown |
| HY-147595 | KRAS G12D inhibitor 15 | Inhibitor | / | Unkown |
| HY-147631 | KRAS G12C inhibitor 50 | Inhibitor | / | Unkown |
| HY-147632 | KRAS G12C inhibitor 51 | Inhibitor | / | Unkown |
| HY-147633 | KRAS G12C inhibitor 52 | Inhibitor | / | Unkown |
| HY-147634 | KRAS G12C inhibitor 53 | Inhibitor | / | Unkown |
| HY-147635 | KRAS G12C inhibitor 54 | Inhibitor | / | Unkown |
| HY-147636 | KRAS G12C inhibitor 55 | Inhibitor | / | Unkown |
| HY-148260 | KRAS G12D inhibitor 16 | Inhibitor | / | Unkown |
| HY-148261 | KRAS G12C inhibitor 56 | Inhibitor | / | Unkown |
| HY-149607 | SHP2-IN-22 | Inhibitor | / | Unkown |
| HY-149705 | ICMT-IN-7 | Inhibitor | / | Unkown |
| HY-149709 | ICMT-IN-35 | Inhibitor | / | Unkown |
| HY-151014 | KRAS ligand 1 | Ligand | / | Unkown |
| HY-151288 | KRAS inhibitor-21 | Inhibitor | / | Unkown |
| HY-151571 | ZG1077 | Inhibitor | / | Unkown |
| HY-151968 | KRAS G12C inhibitor 57 | Inhibitor | / | Unkown |
| HY-151999 | KRAS G12C inhibitor 65 | Inhibitor | / | Unkown |
| HY-152145 | PROTAC SOS1 degrader-3 | / | Unkown | |
| HY-152248 | ARS-2102 | Inhibitor | / | Unkown |
| HY-153412 | KRAS inhibitor-22 | Degrader | / | Unkown |
| HY-153461 | KRAS G12C inhibitor 58 | Inhibitor | / | Unkown |
| HY-153555 | KRAS G12D modulator-1 | Modulator | / | Unkown |
| HY-153674 | PROTAC SOS1 degrader-4 | Degrader | / | Unkown |
| HY-153858 | PHI-501 | Inhibitor | / | Unkown |
| HY-153880 | KRAS degrader-1 | Degrader | / | Unkown |
| HY-153881 | KRAS G12C degrader-1 | / | Unkown | |
| HY-153899 | KRAS G12C inhibitor 59 | Inhibitor | / | Unkown |
| HY-153940 | SOS1/KRAS-IN-1 | Inhibitor | / | Unkown |
| HY-153944 | KRAS G12C inhibitor 60 | Inhibitor | / | Unkown |
| HY-155356A | YN14 (mixture of diastereomers) | / | Unkown | |
| HY-156363 | K-Ras-IN-2 | Inhibitor | / | Unkown |
| HY-156528 | pan-KRAS-IN-4 | Inhibitor | / | Unkown |
| HY-156549 | KRAS G12C inhibitor 61 | Inhibitor | / | Unkown |
| HY-156555 | pan-KRAS-IN-3 | / | Unkown | |
| HY-156671B | RMC-4998 TFA | 99.02% | Unkown | |
| HY-157458 | PDEδ autophagic degrader 1 | / | Unkown | |
| HY-158701 | KRAS G12D inhibitor 23 | Inhibitor | / | Unkown |
| HY-158703 | KRAS G12D inhibitor 24 | Inhibitor | / | Unkown |
| HY-159163 | KRASG12C IN-12 | Inhibitor | / | Unkown |
| HY-159473 | K-Ras-IN-3 | Inhibitor | / | Unkown |
| HY-159475 | KRAS inhibitor-25 | Inhibitor | / | Unkown |
| HY-159476 | KRAS inhibitor-26 | Inhibitor | / | Unkown |
| HY-159611 | KRAS G12C inhibitor 68 | Inhibitor | / | Unkown |
| HY-159790 | Methyl (R)-2-(3-(4-bromobutoxy)isoxazol-5-yl)-3-methylbutanoate | / | Unkown | |
| HY-160220S | KRAS inhibitor-23 | Inhibitor | / | Unkown |
| HY-160445 | KRAS G12D inhibitor 19 | Inhibitor | / | Unkown |
| HY-161173 | PROTAC SOS1 degrader-5 | / | Unkown | |
| HY-161234 | KRAS ligand 3 | Ligand | / | Unkown |
| HY-161236 | KRAS ligand 4 | Inhibitor | / | Unkown |
| HY-161450 | LHF418 | Inhibitor | / | Unkown |
| HY-161654 | PROTAC SOS1 degrader-10 | / | Unkown | |
| HY-161714 | HH0043 | Inhibitor | / | Unkown |
| HY-162281 | PROTAC SOS1 degrader-6 | / | Unkown | |
| HY-162321 | ZINC57632462 | Inhibitor | / | Unkown |
| HY-162366 | KRAS G12D inhibitor 20 | Inhibitor | / | Unkown |
| HY-162439 | pan-KRAS-IN-6 | Inhibitor | / | Unkown |
| HY-162440 | pan-KRAS-IN-7 | Inhibitor | / | Unkown |
| HY-162441 | pan-KRAS-IN-8 | Inhibitor | / | Unkown |
| HY-162442 | pan-KRAS-IN-9 | Inhibitor | / | Unkown |
| HY-162443 | pan-KRAS-IN-10 | Inhibitor | / | Unkown |
| HY-162444 | KRAS G12D inhibitor 22 | Inhibitor | / | Unkown |
| HY-162445S | KRASG12D-IN-3-d3 | / | Unkown | |
| HY-162446 | pan-KRAS-IN-13 | Inhibitor | / | Unkown |
| HY-162536 | Pan-RAS-IN-5 | Inhibitor | / | Unkown |
| HY-162873 | MEK/RAF-IN-1 | Inhibitor | / | Unkown |
| HY-162971 | KRAS inhibitor-33 | Inhibitor | / | Unkown |
| HY-162974 | KRAS inhibitor-34 | Inhibitor | / | Unkown |
| HY-162976 | KRAS inhibitor-35 | Inhibitor | / | Unkown |
| HY-162983 | KRAS inhibitor-36 | Inhibitor | / | Unkown |
| HY-163488 | KRASG12D-IN-4 | Inhibitor | / | Unkown |
| HY-163489 | pan-KRAS-IN-15 | Inhibitor | / | Unkown |
| HY-163582 | PROTAC SOS1 degrader-7 | / | Unkown | |
| HY-163636 | Deltaflexin3 | Inhibitor | / | Unkown |
| HY-163720 | KRAS G12C inhibitor 63 | / | Unkown | |
| HY-163880 | EGFR-IN-119 | Inhibitor | / | Unkown |
| HY-164492 | LSN3074753 | Inhibitor | / | Unkown |
| HY-164632 | KRAS inhibitor-32 | Inhibitor | / | Unkown |
| HY-164645 | pan-KRAS-IN-16 | Inhibitor | / | Unkown |
| HY-168013 | KRASG12C IN-14 | Inhibitor | / | Unkown |
| HY-168055 | (S)-Deoxy-thalidomide | / | Unkown | |
| HY-168056 | KRAS ligand 5 | Degrader | / | Unkown |
| HY-168076 | (S)-Deoxy-thalidomide-2,7-diazaspiro[3.5]nonane-CH2-Me-PIP-Boc | / | Unkown | |
| HY-168442 | KRAS inhibitor-40 | Inhibitor | / | Unkown |
| HY-168512 | BRAFV600E-IN-1 | Inhibitor | / | Unkown |
| HY-168514 | SOS1/EGFR-IN-2 | Inhibitor | / | Unkown |
| HY-168577 | KRAS G12D inhibitor 25 | / | Unkown | |
| HY-168637 | SIAIS562055 | / | Unkown | |
| HY-168672 | E3 Ligase Ligand-linker Conjugate 133 | / | Unkown | |
| HY-168678 | PROTAC K-Ras Degrader-6 | Inhibitor | / | Unkown |
| HY-168700 | KRAS G12D ligand-2 | Inhibitor | / | Unkown |
| HY-168919 | KRASG12C IN-16 | / | Unkown | |
| HY-169311 | KRAS inhibitor-37 | Inhibitor | / | Unkown |
| HY-169312 | KRAS inhibitor-38 | Inhibitor | / | Unkown |
| HY-170326 | HSP90-IN-35 | Inhibitor | / | Unkown |
| HY-170550 | KRAS G12C inhibitor 69 | Inhibitor | / | Unkown |
| HY-170785 | pan-KRAS-IN-17 | Inhibitor | / | Unkown |
| HY-171581 | KRAS G12D-IN-27 | Inhibitor | / | Unkown |
| HY-172221 | SOS1-IN-18 | Inhibitor | / | Unkown |
| HY-172626 | KRAS G12D inhibitor 28 | Inhibitor | / | Unkown |
| HY-172919 | PDEδ/NAMPT IN-1 | / | Unkown | |
| HY-173047 | KRASG12C IN-15 | Inhibitor | / | Unkown |
| HY-173250 | YN14-H | / | Unkown | |
| HY-173252 | KRASG12C ligand-1 | Inhibitor | / | Unkown |
| HY-173329 | KRAS-IN-41 | Inhibitor | / | Unkown |
| HY-173341 | SOF-436 | Inhibitor | / | Unkown |
| HY-173632A | AMG410 diTFA | Inhibitor | / | Unkown |
| HY-174088 | CDK4/6/BRD4-IN-2 | / | Unkown | |
| HY-174243 | KRASG12D-IN-5 | Inhibitor | / | Unkown |
| HY-174254 | AKT-IN-28 | / | Unkown | |
| HY-174261 | KRAS-IN-5 | Inhibitor | / | Unkown |
| HY-174379 | NTLiverTac PDE6D degrader-1 | / | Unkown | |
| HY-174851 | KRAS G12C-IN-70 | Inhibitor | / | Unkown |
| HY-175025 | CH091138 | Degrader | / | Unkown |
| HY-175144 | KRASG12D-IN-6 | Inhibitor | / | Unkown |
| HY-175244 | SOS1-IN-20 | Inhibitor | / | Unkown |
| HY-175265 | PQ32 | / | Unkown | |
| HY-175326 | SOS1-IN-21 | Inhibitor | / | Unkown |
| HY-175419 | TBIA | Inhibitor | / | Unkown |
| HY-175529 | KRASG12D-IN-7 | / | Unkown | |
| HY-175560 | SOS1-IN-22 | Inhibitor | / | Unkown |
| HY-175575 | SOS1 ligand-2 | Ligand | / | Unkown |
| HY-175583 | KRASG12C ligand-2 | Ligand | / | Unkown |
| HY-175673 | LCB-2151 | / | Unkown | |
| HY-175860 | KRAS G12D ligand-Linker Conjugate 2 | / | Unkown | |
| HY-175870A | (7R)-Eras-4001 | Inhibitor | 97.02% | Unkown |
| HY-175870S | Eras-4001-d6 | Inhibitor | / | Unkown |
| HY-175891 | POI ligand-5 | / | Unkown | |
| HY-176170 | SOS1-IN-19 | Inhibitor | / | Unkown |
| HY-176250 | KRAS-IN-43 | Inhibitor | / | Unkown |
| HY-176341S | KRAS 2B G13D mutant, Arg-13C6,15N4, Lys-13C6,15N2 | / | Unkown | |
| HY-176342S | KRAS 2B Q61H mutant, Arg-13C6,15N4, Lys-13C6,15N2 | / | Unkown | |
| HY-176353S | KRAS 2B G13C mutant, Arg-13C6,15N4, Lys-13C6,15N2 | / | Unkown | |
| HY-176354S | KRAS 2B G12V mutant, Arg-13C6,15N4, Lys-13C6,15N2 | / | Unkown | |
| HY-176355S | KRAS 2A, U-15N | / | Unkown | |
| HY-176356S | KRAS 2B, Arg-13C6,15N4, Lys-13C6,15N4 | / | Unkown | |
| HY-176357S | KRAS 2B G12R mutant, Arg-13C6,15N4, Lys-13C6,15N2 | / | Unkown | |
| HY-176358S | KRAS 2B G12C mutant, Arg-13C6,15N4, Lys-13C6,15N2 | / | Unkown | |
| HY-176359S | KRAS 2B G12D mutant, Arg-13C6,15N4, Lys-13C6,15N2 | / | Unkown | |
| HY-176419 | KRAS inhibitor-42 | Inhibitor | / | Unkown |
| HY-176490 | pan-KRAS ligand 3 | / | Unkown | |
| HY-176491 | Alkyne-pyrazine-O-piperidine-(1-methylcyclopropyl)methanol | Chemical | / | Unkown |
| HY-176492 | E3 Ligase Ligand-linker Conjugate 193 | Chemical | / | Unkown |
| HY-176787 | KRAS G12C Ligand-Linker Conjugates 1 | Inhibitor | / | Unkown |
| HY-176792A | (R)-ACBI-4 | Degrader | / | Unkown |
| HY-176870 | KRAS-IN-42 | Inhibitor | / | Unkown |
| HY-176917 | E3 ligase Ligand 76 | / | Unkown | |
| HY-176918 | K-Ras ligand-Linker Conjugate 8 | Degrader | / | Unkown |
| HY-177731 | MG-Lin1 | / | Unkown | |
| HY-178042 | SS-3091 | Inhibitor | / | Unkown |
| HY-178044 | SOS1-IN-24 | Inhibitor | / | Unkown |
| HY-178076 | Pomalidomide-C12-NH2 | / | Unkown | |
| HY-178224 | Morindone | / | Unkown | |
| HY-178497 | ZJK-807 | / | Unkown | |
| HY-178501 | KRAS-IN-45 | Inhibitor | / | Unkown |
| HY-178502 | KRAS-IN-46 | Inhibitor | / | Unkown |
| HY-178873 | PROTAC K-Ras Degrader-7 | Degrader | / | Unkown |
| HY-178874 | E3 ligase Ligand 75 | / | Unkown | |
| HY-178875 | Nrf2 activator-22 | Activator | / | Unkown |
| HY-178888 | Nrf2 ligand-Linker Conjugate 2 | / | Unkown | |
| HY-178910 | Mcl-1-IN-20 | / | Unkown | |
| HY-179058 | JOSD2-IN-1 | Inhibitor | / | Unkown |
| HY-179253 | KRAS-IN-47 | Inhibitor | / | Unkown |
| HY-179254 | Mal-L-Dap(Boc, t-BuOAc)-Pfp Ester | / | Unkown | |
| HY-179300 | KRAS-IN-48 free base | Inhibitor | / | Unkown |
| HY-179300A | KRAS-IN-48 | Inhibitor | / | Unkown |
| HY-179318 | KRAS G12D-IN-32 | Inhibitor | / | Unkown |
| HY-179403 | KRASG12C IN-17 | Inhibitor | / | Unkown |
| HY-179404 | KRASG12C IN-18 | Inhibitor | / | Unkown |
| HY-179414 | KRAS G12D-IN-34 | Inhibitor | / | Unkown |
| HY-179443 | SOS1-IN-25 | Inhibitor | / | Unkown |
| HY-179452 | KRAS G13D-IN-2 | Inhibitor | / | Unkown |
| HY-179480 | G-quadruplex ligand 4 | / | Unkown | |
| HY-179484 | KRASG12C IN-19 | Inhibitor | / | Unkown |
| HY-179534 | G13Ci-22 | Inhibitor | / | Unkown |
| HY-179536 | KRAS-IN-49 | Inhibitor | / | Unkown |
| HY-179702 | KD36 | / | Unkown | |
| HY-180298 | KRAS G12C-IN-71 | Inhibitor | / | Unkown |
| HY-180607 | KRAS-IN-50 | Inhibitor | / | Unkown |
| HY-180885S | KRAS G12D-IN-35 | Inhibitor | / | Unkown |
| HY-180920 | KRAS G12D-IN-36 | Inhibitor | / | Unkown |
| HY-181020 | Deltafluorine | Inhibitor | / | Unkown |
| HY-181284 | BYBC-1 | / | Unkown | |
| HY-181420 | (S,R,S)-BBO-11818 | / | Unkown | |
| HY-181570 | KRAS G12C-IN-73 | / | Unkown | |
| HY-181704 | KRAS-IN-54 | Inhibitor | / | Unkown |
| HY-181716 | KRAS G12C-IN-74 | / | Unkown | |
| HY-181728 | MS243 | Degrader | / | Unkown |
| HY-181733 | KRAS G12D ligand-3 | Degrader | / | Unkown |
| HY-181734 | E3 Ligase Ligand-linker Conjugate 224 | / | Unkown | |
| HY-181807 | SOS1/KRAS-IN-2 | / | Unkown | |
| HY-181883 | KRAS-IN-55 | Inhibitor | / | Unkown |
| HY-181889 | KRAS G12C-IN-75 | Inhibitor | / | Unkown |
| HY-181913 | KRAS G12C-IN-76 | Inhibitor | / | Unkown |
| HY-181964 | KRAS G12C-IN-77 | / | Unkown | |
| HY-181965 | KRAS G12C-IN-78 | Inhibitor | / | Unkown |
| HY-182044 | MRTX849-amide-C4-(o)-carborane | / | Unkown | |
| HY-182055 | Anticancer agent 309 | / | Unkown | |
| HY-182241 | JR4-187 | / | Unkown | |
| HY-182411 | KRAS-IN-56 | Inhibitor | / | Unkown |
| HY-182706 | NSC 373981 | Inhibitor | / | Unkown |
| HY-182749 | KRAS-IN-58 | Inhibitor | / | Unkown |
| HY-182883 | KRASG12C IN-20 | Inhibitor | / | Unkown |
| HY-182994 | pan-KRAS-IN-20 | Inhibitor | / | Unkown |
| HY-183355 | KRAS G12D-IN-37 | / | Unkown | |
| HY-183365 | SL43 | Inhibitor | / | Unkown |
| HY-183625 | PCA-IN-1 | Inhibitor | / | Unkown |
| HY-183645 | KRAS G12C-IN-79 | Inhibitor | / | Unkown |
| HY-183741 | VVD-844 | Inhibitor | / | Unkown |
| HY-184010 | KRASG12D-IN-8 | Inhibitor | / | Unkown |
| HY-184412 | SDUY104 | / | Unkown | |
| HY-184422 | SOS1-IN-26 | / | Unkown | |
| HY-184423 | SOS1-IN-27 | / | Unkown | |
| HY-184586 | SOS1-IN-28 | Inhibitor | / | Unkown |
| HY-184855 | (S,S,S,S)-AHPC-Me | / | Unkown | |
| HY-184892 | RMC-8839 | / | Unkown | |
| HY-184902 | FAK-IN-32 | / | Unkown | |
| HY-184930 | SOS1 ligand-4 | Ligand | / | Unkown |
| HY-185205 | VVD-484 | Inhibitor | / | Unkown |
| HY-185217 | PPI stabilizer-1 | / | Unkown | |
| HY-186024 | KRAS-IN-51 | Inhibitor | / | Unkown |
| HY-186086 | RM-041 | Inhibitor | / | Unkown |
| HY-186225 | KV-14 | / | Unkown | |
| HY-186226 | KVL-9 | Degrader | / | Unkown |
| HY-186283 | GNE-0749 | Inhibitor | / | Unkown |
| HY-186286 | KRAS-IN-63 | Inhibitor | / | Unkown |
| HY-18652A | Avutometinib potassium | Inhibitor | / | Unkown |
| HY-187180 | GNE-8025 | / | Unkown | |
| HY-187519 | KRAS-IN-61 | Inhibitor | / | Unkown |
| HY-187520 | KRAS-IN-62 | Inhibitor | / | Unkown |
| HY-187863 | Debecarasib | Inhibitor | / | Unkown |
| HY-187874 | Zecdarasib | Inhibitor | / | Unkown |
| HY-187998 | AM-8719 | Inhibitor | / | Unkown |
| HY-189129 | RAS GTPase-IN-3 | Inhibitor | / | Unkown |
| HY-19315 | SML-8-73-1 | Inhibitor | / | Unkown |
| HY-D3584 | AF647 Picolyl Azide | / | Unkown | |
| HY-N8387 | Neogrifolin | Inhibitor | / | Unkown |
| HY-P10847 | KS-58 | Inhibitor | / | Unkown |
| HY-P11356 | KRAS G12V Peptide | / | Unkown | |
| HY-P11357 | KRAS G12C Peptide | Activator | 98.86% | Unkown |
| HY-P11901 | KH-1 | / | Unkown | |
| HY-P2265 | SAH-SOS1A | Inhibitor | / | Unkown |
| HY-P3129 | KRAS G13D peptide, 25 mer | / | Unkown | |
| HY-P3430 | JM3A | / | Unkown | |
| HY-RS07427 | Kras Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS09558 | NRAS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010270A | Aurothiomalate disodium | Inhibitor | / | Unkown |
| HY-W1126467 | RAS-IN-5 | Inhibitor | / | Unkown |
| HY-W556631 | LZTR1-KRAS modulator 1 | Activator | / | Unkown |
| HY-101354A | R-IMPP hydrochloride | / | Unkown | |
| HY-112541 | 21-Hydroxyoligomycin A | Inhibitor | / | Unkown |
| HY-114277S2 | Sotorasib-d3 | Inhibitor | / | Unkown |
| HY-114894 | 2C07 | Inhibitor | / | Unkown |
| HY-120885 | (+)-Oxanthromicin | Modulator | / | Unkown |
| HY-121459 | Neoantimycin | Modulator | / | Unkown |
| HY-149710 | POP-3MB | Inhibitor | / | Unkown |
| HY-157067 | KRAS G12C inhibitor 62 | Inhibitor | / | Unkown |
| HY-161655 | SOS1 Ligand intermediate-5 | Inhibitor | / | Unkown |
| HY-161656 | PIP-C-3-Azaspiro[5.5]undecane-boc | / | Unkown | |
| HY-164389 | SML-10-70-1 | / | Unkown | |
| HY-164427 | SHP2-IN-31 | Inhibitor | / | Unkown |
| HY-164513 | NHTD | Inhibitor | / | Unkown |
| HY-164529 | SJ-C1044 | Inhibitor | 98.63% | Unkown |
| HY-168075 | Boc-PIP-Me-CH2-2,7-diazaspiro[3.5]nonane | / | Unkown | |
| HY-168671 | pan-KRAS ligand 1 | Inhibitor | / | Unkown |
| HY-168680 | E3 Ligase Ligand-linker Conjugate 135 | / | Unkown | |
| HY-184821 | KRAS G12C-IN-80 | Inhibitor | / | Unkown |
| HY-187067 | K-Ras ligand-Linker Conjugate 9 | Ligand | / | Unkown |
| HY-187068 | 1-Methylpyrrolidine(2-CH2OH)-PEG4-NH2 | / | Unkown | |
| HY-42936 | ARS-1620 intermediate | / | Unkown | |
| HY-W142207 | (E)-3-Chloroacrylic acid | / | Unkown | |
| HY-W335254 | Deltarasin trihydrochloride | Inhibitor | / | Unkown |
| HY-W999529 | KRAS G12C degrader-2 | / | Unkown |
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991743 | Anti-KRAS Antibody | / | Unkown | |
| HY-P992366 | HFB200901 | Inhibitor | / | Unkown |